جست‌وجوی استاد و پژوهشگر

Ben Z. Stangerمشاهده پروفایل

استاد

• Pancreatic Cancer
• Cellular Plasticity
• Tumor Immunology
• +۳ مورد دیگر

Ben Z. Stanger, M.D., Ph.D. is the Hanna Wise Professor in Cancer Research at the University of Pennsylvania's Perelman School of Medicine, with appointments in the Department of Medicine and Cell and Developmental Biology. He serves as Director of the Penn Pancreatic Cancer Research Center (PCRC) and is an active member of the Abramson Cancer Center, Institute for Diabetes, Obesity and Metabolism, Institute for Medicine and Engineering, and Institute for Regenerative Medicine. His laboratory is housed in the Biomedical Research Building II/III on the Penn campus in Philadelphia. Education: SB (Life Sciences) from Massachusetts Institute of Technology, 1988 MD and PhD (Genetics) from Harvard Medical School, 1997 Dr. Stanger's research focuses on pancreatic ductal adenocarcinoma (PDAC), which is poised to become the second leading cause of cancer death in the United States. His laboratory investigates how pancreatic tumors metastasize early in disease progression and identifies therapeutic vulnerabilities through studies of the tumor microenvironment, metabolism, cellular plasticity, and metastasis biology. His team employs genetically engineered mouse models that recapitulate human disease features, functional genomics, epigenetic analyses, and advanced in vitro culture systems. Analysis of Dr. Stanger's recent publications (2019-2024) reveals a consistent focus on pancreatic cancer biology with increasing emphasis on tumor immunology and therapeutic resistance mechanisms. His research has evolved from fundamental studies of tumor-stroma interactions toward more translational investigations of KRAS inhibition, immune microenvironment regulation, and cellular reprogramming in cancer. Recent work demonstrates how tumor plasticity drives resistance to immunotherapy and how metabolic adaptations allow cancer cells to survive nutrient-deprived conditions. Dr. Stanger maintains an active laboratory with diverse personnel including postdoctoral researchers, graduate students, research specialists, and administrative support. His lab has published in high-impact journals including Nature Communications, Cancer Discovery, Cancer Research, and Science. In addition to his research, Dr. Stanger has authored the book "From One Cell: A Journey into Life's Origins and the Future of Medicine" which explores embryonic development through the lens of scientific history. Research Team: Principal Investigator: Ben Stanger, MD, PhD Research Specialists: Chenghua Yang (Lab Manager), Lily Watson (Assistant Lab Manager) Research Coordinator: Sean O'Connor Postdoctoral Researchers: Austin Good, Cole Edwards, Feiyan Mo, Minh Than Graduate/Post-Graduate Students: Erin Hollander, Benjamin Kahn, Jayne McDevitt, Margo Orlen, William Sullivan, Jane Xie Undergraduate Researcher: Shreya Nair Executive Administrator: Fran Tucker

Filipe Pereiraمشاهده پروفایل

استاد

• Cellular Reprogramming
• Hematopoiesis
• Immunology
• +۵ مورد دیگر

Filipe Pereira is a Professor and Senior Lecturer at Lund University's Faculty of Medicine, where he holds a Wallenberg Molecular Medicine Fellowship and leads the Cell Reprogramming in Hematopoiesis and Immunity research team within the Division of Molecular Medicine and Gene Therapy. His work contributes to UN Sustainable Development Goals related to health and well-being. Dr. Pereira's research focuses on understanding the molecular determinants of cell reprogramming and hematopoietic specification. His laboratory investigates how cellular identities are specified during development, with particular emphasis on Hematopoietic Stem Cells (HSCs) for their regenerative potential and Dendritic Cells (DCs) as key orchestrators of immunity. The team explores experimental approaches to cell reprogramming including nuclear transfer, cell fusion, and transcription factor expression to develop new therapies for immune and blood diseases. Analysis of Dr. Pereira's 98 research outputs reveals a strong focus on cellular reprogramming techniques for immunotherapy applications, particularly in cancer treatment. His work spans molecular biology, immunology, and stem cell research, with significant contributions to understanding transcription factor networks that control cell fate decisions. The research has practical applications in regenerative medicine and cancer immunotherapy, with several publications in high-impact journals including Nature Communications and Science Immunology. Scientific Recognition: Imperial College Emerging Alumni Leader Award (2025) ERC Proof of Concept grant (2024) Pfizer-Portugal award in basic research (2024) ERC Proof of Concept Grant (2023) Eric K. Fernströms Prize to young particularly promising researchers (2023) Dr. Pereira actively supervises graduate students and postdoctoral researchers, with 12 PhD students and 8 postdocs under his mentorship. He leads multiple research projects including 'In Vivo Dendritic Cell Reprogramming Immunotherapy' and 'Functional chemical reprogramming of cancer cells to induce antitumor immunity,' funded by organizations including the European Commission and Cancer Research Institute. His laboratory has developed innovative approaches to reprogram somatic cells into desired hematopoietic cell types, with significant implications for therapeutic applications. The Cell Reprogramming in Hematopoiesis and Immunity team collaborates extensively across international boundaries, with research outputs picked up by numerous news outlets and referenced in patents and Wikipedia pages, demonstrating the broad impact of their work in the scientific community and beyond.

Zhang Yangمشاهده پروفایل

دانشیار

• Artificial Intelligence in Biomedical Imaging
• Deep Learning for Omics Data Analysis
• Pathogen Detection and Diagnostics
• +۷ مورد دیگر

Zhang Yang is an Associate Professor at the School of Medical Engineering, Harbin Institute of Technology (Shenzhen), with a joint appointment as Visiting Professor at the University of Tokyo starting in July 2024. He holds a PhD from the University of Cambridge's Department of Pathology and an M.Phil. from the University of Hong Kong's HKU-Pasteur Research Center. Previously, he served as an Assistant Professor at Harbin Institute of Technology (Shenzhen) from September 2015 to December 2020. His research integrates computational and experimental approaches to address challenges in pathogen and cancer research. On the computational side, his work focuses on developing AI-powered microscopic imaging systems, applying deep learning to analyze multi-omics data (including proteins, DNA, miRNAs, LncRNAs, and mRNAs), and utilizing deep learning in cheminformatics for drug discovery. On the experimental side, his laboratory combines imaging, high-throughput sequencing, mass spectrometry, and chemical biology to understand disease mechanisms at the molecular level. His publication record demonstrates significant impact, with over 50 SCI-indexed papers in high-impact journals including Nature Communications, Briefings in Bioinformatics, Bioinformatics, Analytical Chemistry, and Trends in Biotechnology. His work has been cited by prestigious journals such as Nature Reviews Methods Primers and Nature Communications, with three ESI highly cited papers. His research spans multiple interdisciplinary fields, combining artificial intelligence with biomedical applications to advance diagnostic and therapeutic approaches. World's Top 2% Scientists 2021 Fellow of the Royal Society of Biology Three ESI Highly Cited Papers Five authorized national invention patents As an academic leader, he serves as Associate Editor for BMC Biology and Frontiers in Microbiology, Academic Editor for PLOS Genetics, Editorial Board Member for Communications Biology, and Guest Editor for a Special Issue on AI in analytical chemistry in Trends in Analytical Chemistry. His laboratory actively collaborates with international institutions, with graduates pursuing further studies at Hong Kong Chinese University, Hong Kong University of Science and Technology, Hong Kong Polytechnic University, Macau University, and the University of New South Wales. He teaches Introduction to Modern Biology for undergraduates and Bioanalytical Chemistry for graduate students.

Aly Karsanمشاهده پروفایل

استاد

• Leukemia
• Hematopoiesis
• Genomics
• +۸ مورد دیگر

Aly Karsan is a Professor in the Department of Pathology and Laboratory Medicine at the University of British Columbia (UBC) and a Distinguished Scientist at Canada’s Michael Smith Genome Sciences Centre at BC Cancer. His research focuses on the molecular basis of myeloid leukemias, aging-related cancer resistance, and clinical genomics innovation. Affiliations: Faculty of Medicine (UBC), School of Biomedical Engineering (UBC), BC Cancer Research Institute, Centre for Blood Research (UBC) Clinical leadership: Established first clinically-accredited Next-Generation Sequencing lab in Canada Research Interests Dr. Karsan investigates: Genomic and epigenomic aberrations in aging-related leukemia Role of noncoding RNAs and innate immune signaling in blood cancers Embryonic blood stem cell emergence via Sash1 signaling Clonal interactions in acute myeloid leukemia (AML) Mechanisms of lenalidomide resistance in myelodysplastic syndromes Scientific Contributions Recent publications demonstrate expertise in: NGS technology validation Genetic barcoding systems TGFβ signaling in hematopoiesis Bayesian network diagnostics Awards & Recognition Tier 1 Canada Research Chair in Blood Cancers John Auston BC Cancer Foundation Clinical Scientist Award Health Employers Association of BC Gold Apple Award for Innovation Multiple CIHR Clinician-Scientist and MSFHR Scholar awards Labs & Collaborations Leads the Karsan Lab at BC Cancer Research Institute and coordinates a Terry Fox Research Institute Program Project with six principal investigators.

Wendy Robinsonمشاهده پروفایل

استاد

• Medical Genetics
• Epigenetics
• Fetal Development
• +۴ مورد دیگر

Wendy P. Robinson is a Professor in the Department of Medical Genetics at the University of British Columbia Faculty of Medicine , and a Senior Scientist at the BC Children’s Hospital Research Institute . She holds the CIHR Sex and Gender Science Chair . Research Interests: Genetics and epigenetics of early human development, placental function in pregnancy complications (fetal growth restriction, preterm birth), DNA methylation, non-coding RNA, sex differences, and polymorphisms. Her lab employs genomic and bioinformatic tools to study placental health and its impact on newborn outcomes. Recent Publications (2025-2024) focus on X-chromosome inactivation patterns in placenta, cell-type specific DNA methylation, maternal socioeconomic effects on placental epigenetics, and modeling placental development with organoids. Key themes include sex-specific epigenetic regulation , maternal-fetal interactions , and human placental methylome . Awards: UBC Faculty of Medicine Distinguished Achievement Award (2018), with trainees receiving the James Miller Memorial Prize and Mary-Jane Carroll Trainee Award. Students & Collaborations: Supervised PhD/MSc students include Li Qing Wang, Icíar Fernández Boyano, Giulia Del Gobbo, Victor Yuan, and Magda Price. Collaborators span the Alex Beristain Lab and University of Toronto institutions. Laboratory Activities: Regular team-building events like mountain hikes, climbing outings, and kayaking trips, alongside providing open access to epigenetic tools (e.g., Bisearch, SeqDoc) for the research community.

Michael Parkerمشاهده پروفایل

استاد

• Bioethics
• Global Health
• Genomics
• +۳ مورد دیگر

Professor Michael Parker is Director of the Ethox Centre and Professor of Bioethics at the University of Oxford's Nuffield Department of Population Health. He leads the Wellcome Discovery Research Platform for Transformative Inclusivity in Ethics and Humanities (ANTITHESES) and serves as Chair of the Ethics Advisory Board for "Our Future Health" and Cancer Research UK's Research Data Advisory Board. Established the Global Health Bioethics Network (2012) across Kenya, Malawi, Malaysia, South Africa, Thailand, and Vietnam Co-founder of the Oxford-Johns Hopkins Global Infectious Disease Ethics Collaboratory (GLIDE) (2020) Member of WHO's Expert Group on ethics and governance of infectious disease outbreaks His research focuses on ethical dimensions of genomics, pandemic response, and data science, with particular emphasis on moral disagreement and value pluralism. Current projects involve collaborations with the Pandemic Sciences Institute, MalariaGEN, Big Data Institute, UK Biobank, and 100,000 Genomes Project. Recent publications highlight his work in: Ethical challenges of AI in pandemic modeling Authorship equity in biomedical research Equitable access to genomic medicine Ethics of uterus transplantation in global contexts Data governance frameworks for cancer care He has held significant advisory roles including: Non-Executive Director at Genomics England (2013-2022) Member of UK's Scientific Advisory Group for Emergencies (SAGE) during the pandemic Chair of Nuffield Council on Bioethics Working Group on global health emergencies (2018-2020)

Yuè Liمشاهده پروفایل

استاد

• Computational Biology
• Machine Learning
• Population Genetics
• +۴ مورد دیگر

Yuè Li is a Professor in the Department of Computer Science at McGill University, where he leads the Li Lab focused on machine learning applications in genomics and healthcare. His research develops computational methods for analyzing electronic health records (EHR), single-cell multi-omics data, and population genetics. Dr. Li teaches core courses including Applied Machine Learning (COMP 551), Machine Learning in Genomics and Healthcare (COMP 565), and Computer Programming for Life Sciences (COMP 204). His research interests span: AI methods for computational biology and translational healthcare Multi-modal EHR integration and clinical topic modeling Time-series health forecasting and trajectory analysis Single-cell transcriptomics and epigenomics Polygenic risk modeling and causal variant inference Regulatory genomics and functional annotation integration Publications demonstrate strong focus on transformer architectures for healthcare forecasting, Bayesian methods for genomic inference, and neural topic models for clinical phenotyping. Recent work emphasizes foundation models for single-cell data and federated learning for EHR analysis. Scientific Awards: KDD HealthDay2022 Best Paper Award for seed-guided topic modeling Dr. Li mentors graduate students and postdoctoral researchers working on machine learning applications in biomedical domains. Current lab members include Master's students Bo-Hong Wang, Claris Gu, Neda Esfehani, and Ruilin Wang, along with postdoctoral researcher Dr. Jun Bai. The Li Lab operates within McGill's School of Computer Science, developing computational frameworks to integrate heterogeneous biomedical data for improved disease understanding and clinical decision support.

• Data Mining
• Bioinformatics
• Machine Learning
• +۳ مورد دیگر

Domingo Savio Rodríguez Baena is a Professor at Pablo de Olavide University, affiliated with the Department of Computer Languages and Systems. His research focuses on data mining, bioinformatics, and computational biology, with a particular emphasis on biclustering algorithms, gene co-expression networks, and high-performance computing applications. PhD in Engineering, Data Science, and Bioinformatics (2012) from Pablo de Olavide University His work spans interdisciplinary domains, including recommender systems , livestock behavior analysis , and biological data interpretation . Recent articles highlight his contributions to multi-GPU optimization , ensemble learning , and historical database construction . Key collaborations include the DATAi Intelligent Data Analysis and DASE Data Analytics Science & Engineering research groups. He has developed tools like the CyEnGNet–App for gene network visualization and BIGO for gene enrichment analysis. Contact: dsrodbae@upo.es

• Distributed computing
• Real-time computing
• Algorithms and lower bounds
• +۳ مورد دیگر

Nancy A. Lynch is the NEC Professor of Software Science and Engineering and Professor of Electrical Engineering and Computer Science at the Massachusetts Institute of Technology, where she heads the Theory of Distributed Systems (TDS) group within CSAIL. Research Interests Distributed computing algorithms and lower bounds Real-time and fault-tolerant systems Formal modelling and verification Wireless network algorithms Biological distributed algorithms Neural computation and spiking networks Across her work, Lynch blends rigorous theoretical analysis with practical relevance, tackling problems ranging from consensus and leader election in unreliable networks to modelling decision-making circuits in the brain. Publications & Trends Since 2020 she has published extensively on distributed algorithms , swarm robotics , neuromorphic architectures , and biologically-inspired computation . Notable recent directions include hierarchical concept learning in spiking neural networks, nanobot locomotion modelling for cancer detection, and superconducting nanowire platforms for energy-efficient neural hardware. Scientific Awards & Honors Best Paper Award, OPODIS 2018 Best Paper Award, IEEE NCA 2014 Highlight Paper, Neuromorphic Computing and Engineering 2022 Teaching & Advising Lynch teaches core graduate and undergraduate subjects at MIT including 6.042J Mathematics for Computer Science , 6.852J/18.437 Distributed Algorithms , and 6.885/6.006 Algorithms . She has supervised dozens of PhD students and post-docs whose names are listed on her Past Students page. Laboratory & Teams She leads the Theory of Distributed Systems (TDS) Group , a vibrant research team within MIT CSAIL . TDS is part of the larger Theory of Computation group and hosts weekly seminars, reading groups, and collaborative projects with partners across MIT and worldwide.

• Neuroscience
• Auditory Neuroscience
• Neuronal Microcircuits
• +۳ مورد دیگر

Dr. Albert Berrebi is a Professor and Vice-Chair for Research in the Department of Neuroscience at the West Virginia University School of Medicine . He also holds a faculty position at the Rockefeller Neuroscience Institute and is a member of the WVU Cancer Institute Research Programs . Research Interests: The Berrebi lab investigates the organization of neuronal microcircuits in the central auditory pathway, focusing on chemical phenotypes via immunocytochemical techniques. Their work employs: Brain microinjections for tract-tracing Electron microscopy for ultrastructural analysis In vivo extracellular recordings of auditory neurons Pharmacological receptor blocking to study inhibition Key research areas span the superior olive nuclei (MNTB and SPON), synaptic connectivity, and auditory prosthetics. Recent publications highlight studies on forward masking, postinhibitory rebound spiking, and ketamine effects. Techniques: The lab integrates anatomical, physiological, and cytological methods, including light/electron microscopy and electrophysiology. Their long-term goal is to advance understanding of auditory neural mechanisms and improve cochlear prostheses for hearing impairment.

• Electrical Machines
• Energy Conversion
• Permanent Magnet Motors
• +۳ مورد دیگر

Lale Tükenmez Ergene is a Professor at Istanbul Technical University 's Department of Electrical Engineering, specializing in Electrical Machines and Energy Conversion . Her work bridges theoretical research and practical applications in motor design for electric vehicles and home appliances. Ph.D. in Electrical Engineering from Rensselaer Polytechnic Institute 20+ years of academic and administrative leadership Focus areas: Permanent Magnet Motors, Synchronous Reluctance Motors, and Sensorless Control Systems Her research explores: Optimization of traction motors for electric vehicles Advanced sensorless control algorithms for motor drives Reduction of voltage distortion in high-performance motors Integration of predictive diagnostics in motor systems Applications of neurofuzzy control systems in multicopters Recent publications highlight trends in PMaSynRM parameter estimation , flux weakening capabilities , and real-time motor diagnostics . Her work spans both traditional electrical engineering and cross-disciplinary innovations like VR-based language learning systems for EU workforce mobility. Scientific recognition includes: Best Poster Paper Award (2016) 2nd Prize in Graduation Design Competition (2015) Doctoral Thesis Excellence Award (2015) She leads projects such as: Pmasynrm's Innovative Real-Time Model Diagnostic System (2021-2024) Sensorless Magnet-Supported Motor Drive for Washing Machines (2019-2022) VR-based Business English Training for Engineers (2018-2022)

• Cancer
• Liver Pathology
• Tumor Suppression
• +۶ مورد دیگر

Professor Alain de Bruin (born 1968) is a distinguished academic at Utrecht University, serving as Professor in the Department of Biomolecular Health Sciences within the Faculty of Veterinary Medicine. Since January 1, 2020, he has been Head of the Department of Biomolecular Health Sciences. His academic journey began with veterinary medicine studies at the University of Hannover in Germany, followed by a PhD from the University of Bern in Switzerland in 1999. After specializing in veterinary pathology and completing a postdoctoral position at Ohio State University, he was appointed professor of pathobiology at Utrecht University in 2005. In 2010, he founded the Netherlands Molecular Pathology Center (UU/UMCG) and became an honorary professor of molecular pathology at the University of Groningen in 2014. Professor de Bruin's research primarily focuses on cancer biology, liver pathology, tumor suppression mechanisms, and aging processes. His expertise includes in vivo modeling, cell cycle analysis, generating transgenic mouse models, pathological analysis of animal disease models, and single-cell transcriptomics. His work centers on proteins that regulate cell proliferation, particularly E2F transcription factors, which he has discovered play critical roles in inhibiting cancer cell growth. His research themes span Life Sciences, Regenerative Medicine, and the Utrecht Platform for Organoid Technology. Analysis of his recent publications reveals a consistent research trajectory centered on cell cycle regulation, particularly the atypical E2F transcription factors (E2F7 and E2F8), and their roles in cancer development, polyploidization, and liver disease. His work demonstrates how these factors influence tumor suppression, angiogenesis, and cellular responses to DNA damage. The publications span multiple disciplines including cancer biology, molecular oncology, hepatology, and regenerative medicine, with applications in both human and veterinary medicine. Professor de Bruin has held significant leadership positions, including chairing the research council (2017-2019) and coordinating the 'Regenerative Medicine, Stem Cells, and Cancer' research program (2013-2019). He serves on the editorial board of 'Frontiers in Cell and Developmental Biology' and participates in review committees for NWO-Rubicon/Veni, the research alliance UTwente/UU/UMCU, and the Comprehensive Cancer Center at Ohio State University. His laboratory work has made significant contributions to understanding how E2F transcription factors regulate cell proliferation, with implications for developing novel cancer therapy strategies. His research on polyploidization mechanisms has provided insights into liver regeneration and tumor development, while his work on senescence has implications for aging-related diseases.

Laura Wareingمشاهده پروفایل

پژوهشگر

• Collaborative design
• Participatory design
• Health inequalities
• +۶ مورد دیگر

Laura Wareing is a Researcher at the Lancaster Medical School , with over a decade of experience in co-design methodologies and public sector engagement. Her work bridges health equity , participatory design , and community-driven innovation , particularly focusing on underserved populations in the UK's North West region. PhD in Design (Lancaster University) MA in Multidisciplinary Design Innovation (Northumbria University) BA in Industrial Design (Northumbria University) Research interests center on co-design processes that address health inequalities, improve patient involvement in service design, and build capacity for sustainable collaborative frameworks. Her recent projects focus on prehabilitation services for cancer patients and creating equitable opportunities for marginalized youth through place-based approaches. Her peer-reviewed publications highlight co-design applications in healthcare and social innovation, with trends toward patient-centered tools , systems thinking , and equity-focused service design . Key contributions include the Hexagon Tool for idea generation and the Inspirer newspaper co-created with underrepresented youth. Scientific Recognition: Royal Society of Arts first place award for social change design Laura has led knowledge exchange initiatives with organizations including NHS , Scottish Government , and The V&A Museum . She is principle investigator for the PARITY project (2024-2027) and contributed to the AHRC-funded Design Leadership Fellowship (2020). Her work has generated over £130k in funding for local organizations. As a co-founder of the Leapfrog Project and New IDEAS knowledge exchange initiatives, she has developed tactile tools for collaborative ideation and evaluation. Her research group affiliations include the GRACE team at Lancaster Medical School and ImaginationLancaster design lab.

• Breast Cancer
• Surgical Oncology
• DCIS Management
• +۳ مورد دیگر

Kelly C. Hewitt, MD, FACS, serves as a Clinical Associate Professor in the Department of Surgery at the University of Utah School of Medicine and practices as a breast surgical oncologist at University of Utah Health and Huntsman Cancer Institute. Her clinical expertise encompasses surgical management of malignant and benign breast diseases, with specialized focus on ductal carcinoma in situ (DCIS). Dr. Hewitt's educational background includes: B.A. in Biology from Johns Hopkins University M.D. from Georgetown University School of Medicine General Surgery Residency at the University of Utah School of Medicine Breast Surgical Oncology Fellowship at the University of California, San Francisco School of Medicine Her research centers on minimizing overdiagnosis and overtreatment of DCIS through active surveillance strategies and identifying optimal surgical candidates. She actively investigates clinical trials for early-stage breast cancer and works to enhance healthcare access across the Mountain West region. Dr. Hewitt emphasizes personalized care, collaborating with patients to align surgical plans with personal goals while ensuring disease management efficacy. Analysis of her 2020-2024 publications reveals dominant themes in DCIS management, axillary lymph node assessment, and surgical innovation. Key trends include superparamagnetic iron oxide (SPIO) mapping techniques, mastectomy recurrence patterns, and evidence-based approaches to reduce overtreatment. Her work bridges clinical practice with surgical oncology research to optimize patient outcomes. Professional Recognition: Fellow of the American College of Surgeons (FACS) As national co-principal investigator for the DCIS:RECAST clinical trial and contributor to the I-SPY2 trial network, Dr. Hewitt leads grant-funded research addressing critical gaps in breast cancer care. She mentors surgical trainees in breast oncology while navigating complex patient cases through multidisciplinary collaboration. Within Huntsman Cancer Institute's breast oncology program, Dr. Hewitt collaborates with national consortia to advance surgical techniques and patient-centered care models. Her leadership in Mountain West healthcare access initiatives demonstrates commitment to equitable cancer treatment delivery.

Rui Vinhas da Silvaمشاهده پروفایل

استاد

• National Competitiveness
• Corporate Reputation
• Sustainable Business Practices
• +۵ مورد دیگر

Rui Vinhas da Silva is a Full Professor at ISCTE-IUL and an Associate Professor at the University of Manchester Business School. With a career spanning over two decades, he has contributed extensively to research in national competitiveness, corporate reputation, and sustainable business practices through publications, books, and executive training programs. Education: PhD and Postdoctoral Fellow at the University of Manchester; MBA and Master of Economics from UK and Canada Research Focus: National competitiveness, sustainability in business, marketing strategy, and organizational behavior His recent articles explore topics like AI's role in society, caravan tourism regeneration, and sustainable business models. He has received teaching accolades at ISCTE and leads research initiatives in European networks like COST-CHERN. Silva's work bridges academic rigor with practical applications in consulting and executive education.